GlassScriptPhysician profile
Matthew D Peterson
NPI 1538284567
$8,467.38
in general payments reported to CMS, 2019-2025
43 companies · $1,272 in 2025
The $1,272 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $474 · 2021: $930 · 2022: $1,613 · 2023: $2,070 · 2024: $1,338 · 2025: $1,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,358 · Travel and Lodging: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,358.39 |
| Travel and Lodging | $1,322.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,393.76 | 2021-2025 | Interstim, Altaviva |
| Intuitive Surgical, INC. | $1,322.09 | 2023-2024 | Da Vinci Surgical System |
| Medtronic USA, INC. | $662.47 | 2019-2020 | |
| Boston Scientific Corporation | $464.37 | 2019-2025 | Ams 700, Lithovue Elite, Lithovue |
| Urogen Pharma, INC. | $344.33 | 2022-2025 | Jelmyto |
| Teleflex LLC | $311.91 | 2022-2023 | Urolift |
| Sumitomo Pharma America, INC. | $307.17 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $299.21 | 2019-2023 | Myrbetriq |
| Procept Biorobotics Corporation | $228.28 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Abbvie INC. | $211.25 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $193.32 | 2022-2024 | Prolaris |
| Janssen Biotech, INC. | $155.28 | 2019-2024 | Erleada |
| Siemens Medical Solutions USA, INC. | $133.80 | 2021-2023 | Magnetom Vida |
| Sanara Medtech INC. | $122.85 | 2022 | |
| Amgen INC. | $120.52 | 2019-2021 |
Show all 42 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,770.18 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.